According to the guidelines from the Society of Surgical Oncology (ASCO), all patients newly diagnosed with BC at stages I-III or with de novo stage IV/metastatic disease who are 65 years or younger should be offered BRCA1/2 testing (Formal Consensus; Agreement: 87.5%) [22]. Here, BRCA1 is linked to breast cancer.